Author(s): Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, , Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, , Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S, , Rongioletti F, Ghio L, Ginevri F, Bleidl D, Rinaldi S,
Abstract Share this page
Abstract The cutaneous side-effects of levamisole include non-specific and lichenoid eruptions, fixed drug eruption and, very rarely, cutaneous vasculitis. We describe a distinctive clinical and histological vasculopathy with immunological abnormalities in children with paediatric nephrotic syndrome receiving long-term levamisole treatment. Four boys and one girl were identified. Their average age was 10 years. Levamisole had been used for an average of 24 months. Purpura of the ears was the most common finding corresponding histologically to a vasculopathic reaction pattern ranging from a leucocytoclastic and thrombotic vasculitis to a vascular occlusive disease without true vasculitis but with associated antinuclear, antiphospholipid and anticytoplasmic antibodies. The eruption resolved in all patients 2-3 weeks after the discontinuation of levamisole, but serum autoantibodies persisted for 2-14 months.
This article was published in Br J Dermatol
and referenced in Journal of Arthritis